These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 16613531)
1. The case against excessive cost sharing. Brixner DI Am J Manag Care; 2006 Apr; 12(6 Suppl):S162-4; discussion S167-72; quiz S173-6. PubMed ID: 16613531 [No Abstract] [Full Text] [Related]
2. The case for cost sharing for biologic therapies. Fish L Am J Manag Care; 2006 Apr; 12(6 Suppl):S159-61; discussion S167-72; quiz S173-6. PubMed ID: 16613530 [No Abstract] [Full Text] [Related]
4. Small Changes or Big Ones? The Case of Limits on Prescription Drug Copayments in California. Pyenson B; Dieguez G; Simon K; Bochner A Manag Care; 2018 Jul; 27(7):27-29. PubMed ID: 29989898 [TBL] [Abstract][Full Text] [Related]
6. The great debate part II: should managed care rely on cost sharing to manage big-ticket biologics? Zitter M Am J Manag Care; 2006 Apr; 12(6 Suppl):S153-8; discussion S167-72; quiz S173-6. PubMed ID: 16613529 [No Abstract] [Full Text] [Related]
7. "Build it and they will come?". Giaquinta D Manag Care Interface; 2002 Oct; 15(10):44-5, 47. PubMed ID: 12391817 [No Abstract] [Full Text] [Related]
8. Patient Cost-Sharing and Hospitalization Offsets in the Elderly. Chandra A; Gruber J; McKnight R Am Econ Rev; 2010 Mar; 100(1):193-213. PubMed ID: 21103385 [TBL] [Abstract][Full Text] [Related]
9. Tier 4 drugs and the fraying of the social compact. Lee TH; Emanuel EJ N Engl J Med; 2008 Jul; 359(4):333-5. PubMed ID: 18650510 [No Abstract] [Full Text] [Related]
11. Changes in Consumer Cost-Sharing for Health Plans Sold in the ACA's Insurance Marketplaces, 2015 to 2016. Gabel J; Green M; Call A; Whitmore H; Stromberg S; Oran R Issue Brief (Commonw Fund); 2016 May; 11():1-14. PubMed ID: 27214926 [TBL] [Abstract][Full Text] [Related]
12. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief. Chaps NA Issue Brief Health Policy Track Serv; 2009 Jan; ():1-26. PubMed ID: 19301435 [No Abstract] [Full Text] [Related]
14. Backlash Against Copay Accumulators. Silverman E Manag Care; 2018 Sep; 27(9):15. PubMed ID: 30216152 [TBL] [Abstract][Full Text] [Related]
15. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief. Chaps NA Issue Brief Health Policy Track Serv; 2008 Jan; ():1-23. PubMed ID: 18345558 [No Abstract] [Full Text] [Related]
16. Pharmaceuticals and medical devices: Medicare Part D. Issue brief. Steiner DJ Issue Brief Health Policy Track Serv; 2012 Dec; ():1-32. PubMed ID: 23297447 [No Abstract] [Full Text] [Related]
17. Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment. Schneeweiss S; Patrick AR; Maclure M; Dormuth CR; Glynn RJ Circulation; 2007 Apr; 115(16):2128-35. PubMed ID: 17420348 [TBL] [Abstract][Full Text] [Related]
18. Defined-contribution products and their influence on pharmacy benefit management. Giaquinta D Manag Care Interface; 2003 Aug; 16(8):36-8. PubMed ID: 12964551 [No Abstract] [Full Text] [Related]